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Abstract
Background: Giardia lamblia is a common parasitic cause of infectious gastroenteritis in the United States and
the world and may be linked to an increased risk of chronic gastrointestinal (GI) disorders. We sought to assess
the risk of several chronic GI disorders following Giardia infection among active duty US military personnel.
Methods: This study was designed as a retrospective cohort study in which active duty military personnel with
documented G. lamblia infection were assessed for the subsequent risk of developing a chronic GI disorder
including irritable bowel syndrome (IBS), dyspepsia and gastroesophageal reflux disease (GERD). Post-giardia chronic
GI disorder risk was compared to risk in uninfected personnel matched on several demographic characteristics and
medical encounter information. Data were obtained from the Defense Medical Surveillance System and exposures
(1998–2009) with outcomes identified based on documented medical encounters with specific medical billing
codes. Modified Poisson regression was used to evaluate the relationship between G. lamblia infection and chronic
GI disorders.
Results: A total of 80 Giardia cases were identified for an estimated incidence of 0.55 cases per 100,000 person-years.
Cases were matched to 294 unexposed subjects. After adjusting for important covariates, there was an increased risk
of IBS (relative risk: 2.1, p = 0.03) associated with antecedent Giardia infection.
Conclusion: These data add to a growing body of literature and demonstrate an increased risk of IBS after infection
with G. lamblia.
Keywords: Functional gastrointestinal disorders, Giardia lamblia, Post infectious, Infectious gastroenteritis
Abbreviations: FGD, Functional gastrointestinal disorder; GERD, Gastroesophageal reflux disease; GI, Gastrointestinal;
IBS, Irritable bowl syndrome
Background
Infectious gastroenteritis (IGE) is caused by numerous
bacterial, viral, and parasitic pathogens. Among parasites,
Giardia lamblia, a unicellular eukaryotic microorganism
that causes symptoms of diarrhea, abdominal cramps, and
occasionally nausea and vomiting, is a predominate pa-
thogen. Symptoms of giardiasis usually occur within 1–2
weeks following exposure; however, they can persist for
weeks or even months without proper treatment [1]. Giar-
dia accounts for approximately 77,000 cases of parasitic
foodborne illness annually in the US [2] and is a known
cause of travelers’ diarrhea among civilian and military
travelers [3, 4]. Globally, the burden is even greater with
recent literature from the Foodborne Disease Burden
Epidemiology Reference Group (FERG) estimating 183
million cases and 171,000 disability adjusted life years
(DALYs) attributed to G. lamblia in 2010 [5].
In addition to the acute illness, giardiasis has been
associated with an increased risk of several secondary or
chronic health conditions and is known to cause small
intestinal malabsorption [1]. One such group of sequelae
that has been increasingly associated with other enteric
pathogens are functional gastrointestinal disorders
(FGD). The pathophysiology of FGDs is likely varied and
has yet to be clearly characterized but is typified by the
onset of chronic or recurrent GI symptoms [6]. The
FGDs have been categorized into 24 separate diagnoses
based on the “Rome Diagnostic Criteria” [7, 8]. As a
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group, these disorders are estimated to account for more
than 11 million ambulatory care visits, equating to
roughly four visits for every 100 persons in the United
States [8]. The pathoetiology of these disorders is poorly
understood; however, several mechanisms have been im-
plicated in producing symptoms including gut brain axis
dysfunction, mucosal barrier disruption, gastrointestinal
dysmotility, microbiota disturbances, inflammation,
visceral hypersensitivity, diet, and genetic predispos-
ition [8].
We sought to assess the association between G. lam-
blia infection and several FGD in active duty US military
personnel, a healthy subset of the general travel popula-
tion. The outcomes studied have been previously shown
to be associated with infectious gastroenteritis [8–12];
however, data linking antecedent Giardia infections are
lacking.
Methods
This retrospective cohort study evaluated the risk of PI
sequelae following a documented parasitic IGE episode
compared to the risk of those same outcomes in a co-
hort of unexposed subjects. Exposed subjects were
identified by the International Classification of Diseases,
volume 9 – Clinical Modification (ICD9-CM) codes
using the Defense Medical Surveillance System (DMSS).
Giardia exposure was identified based on a documented
medical encounter with 007.1 visit code. Up to four
unexposed subjects were matched to each Giardia case
based on an unrelated medical encounter within 1 year
of the Giardia exposure exposed. Unrelated medical
encounters codes included the following: acute respira-
tory infections (ICD9-CM: 460–466), pneumonia and
influenza (ICD9-CM: 480–488), infectious of the skin
and subcutaneous tissue (ICD9-CM: 680–686), disloca-
tions (ICD9-CM: 830–839), sprains and strains for joints
and adjacent muscles (ICD9-CM: 840–848), burns (ICD9-
CM: 910–949), fracture of upper or lower limb (ICD9-
CM: 810–829). Additional matching criteria included age
(±1 year), gender, number of prior deployments, medical
treatment facility and type of medical encounter (inpatient
or outpatient). All subjects had a minimum of 1 year of
documented follow-up within the DMSS and were se-
lected from the total active duty US military population
from 1998 to 2009. The outcomes of interest were irritable
bowel syndrome (IBS) (ICD9-CM: 564.1, 306.4), cons-
tipation (ICD9-CM: 564.0), dyspepsia (ICD9-CM: 536.8)
and gastroesophageal reflux disease (GERD) (ICD9-CM:
530.81).
Additional covariates were included to determine their
effect on the risk of PI sequelae. ICD9-CM codes for Axis
I psychological disorders of interest included neurotic dis-
orders (300), personality disorders (301), sexual disorders
(302), acute reaction to stress (308), adjustment reaction
(309), non-psychotic brain syndrome (310), depressive
disorders not elsewhere classified (311), conduct distur-
bances not elsewhere classified (312), emotional disturb-
ance (313), and hyperkinetic syndrome (314).
Incidence of Giardia was estimated based on the num-
ber of cases identified and the total active duty military
population data obtained from the Defense Manpower
Data Center. Descriptive characteristics were calculated
and stratified by exposure. Associations between the
exposure and outcomes were initially explored using
appropriate univariate methods. Modified Poisson re-
gression models using a robust sandwich estimator for
variance were used to investigate the relationship between
giardiasis and each of the outcomes independently [13].
Multivariate models were built for each outcome using
backwards elimination and an alpha = 0.15 to retain vari-
ables. All statistical analyses were conducted using SAS v.
9.3 for Windows (SAS Institute, Cary, North Carolina).
Results
A total of 80 giardiasis cases were identified for an esti-
mated incidence of 0.55 per 100,000 person-years in
males (no female cases were identified). Giardiasis cases
were matched to 294 unexposed subjects for a total sam-
ple size of 374 subjects. All of subjects were male with a
median age of 35 years (interquartile range: 32, 46) at
the time of study completion (Table 1). Over two-thirds
(n = 272) of the study population had at least a high
school education while the remaining (n = 65) had either
bachelor’s (n = 31, 8.2 %) or master’s degrees (n = 34,
11.6 %) (Table 1). Occupation was fairly evenly distrib-
uted among all the possible categories. In terms of
branch of service, many of the study subjects were in the
Navy (31.1 %) followed closely by the Army (29.4 %) and
finally the Marines (22.2 %) (Table 1).
In univariate analyses (Table 2), G. lamblia infection
was associated with an increased risk of IBS (relative risk
{RR} [10]: 2.1; 95 % confidence interval {CI}: 1.1, 3.7)
and dyspepsia (RR: 3.2; 95 % CI: 1.2, 8.9) compared to
unexposed subjects (Table 2). Those individuals that
were diagnosed with an Axis I disorder were also at a
6.7 times (95 % CI: 3.7, 12.2) increased risk for IBS.
GERD (4.0, 95 % CI: 2.9, 5.6), and dyspepsia (RR: 5.4,
95 % CI: 1.7, 16.5) were also significantly associated with
Axis I disorders. Other bacterial and viral IGE episodes
were associated with the development of IBS (RR: 5.9,
95 % CI: 3.2, 10.8), GERD (RR: 2.1, 95 % CI: 1.3, 3.5) and
functional constipation (RR: 9.0, 95 % CI: 2.7, 29.8).
In multivariate models (Table 3), the risk of all out-
comes remained elevated in those with Axis I disorders
with adjusted RR {aRR} ranging from 3.4 to 12.5. Indi-
vidual disorders were not investigated independently due
to low numbers of each diagnosis. In contrast, military
rank and race appeared to have differential effects across
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the outcomes of interest with officers and non-Caucasian
subjects with a decreased risk of IBS, but an increased risk
of functional constipation. After adjustment for covariates
(Table 3), only IBS retained a significant association with
giardiasis (aRR: 2.1, 95 % CI: 1.1, 4.0).
Discussion
This study demonstrated over a 2-fold risk of IBS among
those with an antecedent Giardia infection and an unex-
posed reference population after adjusting for covariates.
While several studies have described the incidence of
FGD following bacterial and viral IGE few have exam-
ined their incidence subsequent to parasitic infection
[8, 14].
The incidence of Giardia reported here is lower than
recorded in another recently published study in this popu-
lation. Specifically, the Medical Surveillance Monthly
Report (MSMR) published in October of 2013 cites an
11-year surveillance period of the US Armed Forces
for gastrointestinal infections [15]. The authors reported
an incidence rate of giardiasis of 6.2 per 100,000. The
study reported here utilized data from 1998 to 2009, while
the MSMR focused on 2002–2012 [15]. The highest rates
of Giardia from the MSMR study were in 2002–2006 and
from 2008 to 2012 [15]. Case diagnosis year was not avail-
able, precluding annual comparisons across the two stud-
ies. One potential reason for the difference in incidence
estimates could be variable inclusion criteria. For inclusion
in this study, a subject could not have a prior documented
medical encounter with any of the outcomes of interest
(IBS, GERD, constipation, dyspepsia) to help cut down on
the likelihood that the outcome of interest could be
attributed to something other than the parasitic exposure.
If a participant had a prior medical encounter with one of
the outcomes of interest it would underestimate the
incidence.
The results of this study are consistent with other
studies reporting an increase in IBS after enteric infec-
tion [16–18]. While not specific to parasitic infections,
two recent meta-analyses have shown that the risk in-
creases 6- to 7-fold after IGE and remains elevated for at
least 2 to 3 years after the initial infection [9, 10]. In only
one prior study has antecedent Giardia infection been
linked to IBS. Following a Giardia outbreak in Bergen,
Norway, investigators found a 46.1 % IBS prevalence in
exposed subjects (46.1 %) compared to 14.0 % in the
control subjects (aRR: 3.4, 95 % CI: 2.9, 3.8) [17].
Similarly, we found a 2.1 increase risk in IBS following
sporadic Giardia infections compared to an uninfected
reference population. The estimate reported here (aRR:
2.1) is lower than that reported in prior systematic
reviews or in the prior G. lamblia outbreak possibly due
to case definitions, study design and/or differences in
study populations. The Bergen study used a question-
naire mailed to participants with standardized questions
where IBS was defined according to the Rome III cri-
teria, whereas we relied on passive surveillance through
DoD medical encounters [17].
Evidence of the association between acute IGE and
development of functional dyspepsia has been accumu-
lating in the literature over the past decade. The findings
of this study support the growing body of evidence
demonstrating an association between acute GI infection
and functional dyspepsia [16, 18]. FGD was the third
Table 1 Demographic characteristics of selected US military
members between 1998–2009
G. lamblia Unexposed Total
N 80 294 374
Age [Median (IQR)] 37.35 (34, 45) 35 (30, 46) 35 (32, 46)
Sex [n (%)]
Male 80 (100) 294 (100) 374 (100)
Race/Ethnicity [n (%)]
Hispanic 13 (16.3) 69 (23.5) 82 (23.7)
White 67 (83.8) 215 (73.1) 282 (75.4)
Other/Unknown 0 (0) 10 (3.4) 10 (2.6)
Education [n (%)]
High School 55 (68.8) 217 (73.8) 272 (72.7)
Some College 10 (12.5) 25 (8.5) 35 (9.4)
College 5 (6.3) 26 (8.8) 31 (8.2)
Graduate School 10 (12.5) 24 (8.2) 34 (11.6)
Unknown 0 (0) 1 (0.3) 1 (0.3)
Rank [n (%)]
Junior enlisted 23 (28.8) 116 (39.5) 139 (50.7)
Senior enlisted 44 (55.0) 130 (44.2) 174 (46.5)
Junior officer 0 (0) 2 (0.7) 5 (0.8)
Senior officer 13 (16.3) 46 (15.6) 59 (15.7)
Service [n (%)]
Army 29 (36.3) 81 (27.5) 110 (29.4)
Coast Guard 0 (0) 12 (4.1) 12 (3.2)
Air force 12 (15) 41 (13.9) 53 (14.2)
Marines 13 (16.3) 70 (23.8) 83 (22.2)
Navy 26 (32.5) 90 (30.6) 116 (31.1)
Military Operation [n (%)]
Iraqi Freedom (Iraq) 17 (21.24) 85 (28.9) 102 (76.7)
Enduring Freedom
(Afghanistan)
8 (10.0) 49 (16.6) 57 (65.4)
Primary Outcomes
Dyspepsia 8 (10.0) 5 (17) 13 (3.5)
Constipation 4 (5.0) 6 (20.4) 10 (2.6)
IBS 16 (20.0) 16 (5.4) 32 (8.5)
GERD 26 (32.5) 51 (17.3) 77 (20.5)
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most prevalent FGD found within the study population
(overall estimate of 3.5 %); however, this is probably an
underestimate. Most studies show the prevalence of
post-infectious FD around 10 % [11]. Quigley and Lacy
reported a prevalence of 12–15 % among the general US
population [19]. A meta-analysis in 2013 estimated a
pooled OR of 2.18 (95 % CI: 1.70, 2.81) for the risk of
developing FD following IGE [12]. Dizdar recently re-
ported that patients with abdominal symptoms after
acute Giardia infection had evidence of enhanced vis-
ceral sensitivity, and 15 of the 22 patients had evidence
of FD indicating that dyspepsia may be attributed to
increased visceral sensitivity that persists after initial in-
fection [16]. A recent study [16].
This study found a similar trend with more cases hav-
ing a GERD diagnosis (32.5 %) compared to controls
(17.3 %); however, this was not significant in multivariate
analyses. A 2012 study looking at three recent norovirus
outbreaks found the risk of GERD is higher among those
who had an IGE diagnosis during a confirmed outbreak
(aRR: 1.39, 95 % CI: 1.07, 1.81) [20]. The potential asso-
ciation between Giardia and functional dyspepsia needs
further study.
The mechanisms by which Giardia infection may
induce chronic, long-term FGD are unclear. Recently,
researchers at the University of Calgary have shown that
infection with Giardia can induce functional changes in
commensal flora composition in a nematode model [21].
In a healthy host, it may be that these infections trigger
the intestinal dysbiosis and altered sensory perception
common noted in many FGDs [22]. Additionally,
Giardia has been shown to disrupt tight junctions, which
perhaps alters gut permeability in a way that alters nor-
mal homeostasis and host-microbiota interactions [23].
The link between giardiasis and post-infectious sequelae
is likely the result of a multi-factorial process in a sus-
ceptible host and understanding these processes and
host characteristics is an ongoing area of research across
multiple institutions.
Psychological comorbidities, such as stress and anx-
iety, are associated with an increased IBS risk, and often
the two conditions occur together [14, 24, 25]. In fact,
we observed a stronger association between axis I disor-
ders and FGDs then was observed with our exposure of
interest (ie, Giardia infection). Several studies have dem-
onstrated a similar association between axis I disorders
and IBS [8, 9, 24, 25]. Additionally, traumatic life events
can often precede the onset of functional bowel disorders
[26]. A meta-analysis conducted in 2002 found that
psychiatric comorbidities were present in up to 94 % of
patients with chronic gastrointestinal disorders, including
IBS [27]. We observed an increase in the risk of IBS,
GERD, dyspepsia, and constipation in subjects with
preceding axis I diagnoses after controlling for relevant
covariates and exposures. These results are consistent
with observed associations between psychological co-
morbidities and IBS [9, 10]. It is important to note, that
the associations between giardia and chronic GI disorders
Table 2 Unadjusted incident rate ratios (95 % confidence intervals) for outcomes of interest and selected covariates evaluating risk
of functional gastrointestinal disorders following acute G. lamblia infection
Covariate Outcome of interest
IBS GERD Dyspepsia Constipation
Non-Caucasian 0.5 (0.2, 1.4) 1.2 (0.8, 1.8) 0.9 (0.3, 3.0) 0.4 (0.1, 2.9)
> High school education 1.5 (0.8, 3.0) 0.9 (0.6, 1.3) 0.8 (0.2, 2.7) 1.7 (0.5, 5.7)
Officer 1.6 (0.7, 3.3) 1.3 (0.9, 2.0) 1.8 (0.6, 5.1) 5.4 (0.7, 43.5)
Non-Army Service 1.8 (0.7, 4.4) 1.5 (1.0, 2.4) 2.3 (0.6, 9.8) 1.7 (0.4, 7.6)
Operational deployment 2.0 (0.7, 5.6) 1.0 (0.5, 2.2) 0.4 (0.1, 3.3) 0.7 (0.1, 7.6)
Axis I disorder 6.7 (3.7, 12.2) 4.0 (2.9, 5.6) 5.4 (1.7, 16.5) 18.4 (4.2, 81.1)
Bacterial or Viral Infection 5.9 (3.2, 10.9) 2.1 (1.3, 3.5) 3.8 (1.0, 15.2) 9.0 (2.7, 29.8)
G. lamblia 2.1 (1.1, 3.7) 1.1 (0.7, 1.6) 3.2 (1.2, 8.9) 1.3 (0.4, 4.8)
Table 3 Adjusted incident rate ratios (95 % confidence intervals) for outcomes of interest and selected covariates evaluating risk of
functional gastrointestinal disorders following acute G. lamblia infection
IBS GERD Dyspepsia Constipation
Officer 0.3 (0.1, 1.0) 1.7 (0.7, 3.9) 1.2 (0.2, 7.8) 6.8 (2.0, 22.8)
Non-Caucasian 0.3 (0.1, 1.0) 1.9 (0.8, 4.3) 1.2 (0.2, 9.7) 2.8 (0.6, 13.2)
Axis I disorder 12.5 (4.1, 37.7) 3.4 (2.4, 4.7) 4.6 (1.3, 16.5) 9.8 (2.2, 43.7)
Bacterial or Viral Infection 2.3 (0.8, 6.4) 1.3 (0.7, 2.4) 1.8 (0.4, 8.2) 2.7 (0.7, 9.2)
G. lamblia 2.1 (1.1, 4.0) 1.0 (0.7, 1.4) 2.6 (0.9, 7.4) 1.2 (0.3, 5.2)
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were noted to be significant when controlling for these
important known covariates. Interactions between IGE
and psychological co morbidities were difficult to investi-
gate due to low numbers of each individual comorbidity.
Limitations inherent in our study may impact the
generalizability of these results. Giardia infections were
identified exclusively among males in this study popula-
tion, perhaps not unsurprising given the study popula-
tion and the inclusion criteria. Interactions between
covariates were not investigated due to a small sample
size of the outcome of interest and relatively low num-
bers of participants within each subcategory of covari-
ates. FGD diagnoses are complicated by their functional
nature and the lack of diagnostic tests [7]. It is also pos-
sible that the observed findings could be the result of an
unmeasured confounder; however, no confounders have
been proposed to date that would differentially affect the
exposed cohort. The etiology of enteric infection is also
complicated by poor diagnostic test utilization and a low
rate of care-seeking behavior in persons with IGE. The
utilization of ICD9-CM codes to identify exposures and
outcomes can be problematic and has been described
elsewhere [28].
Conclusions
Despite the limitations, this study suggests an increased
risk of chronic GI outcomes following Giardiasis similar
to what has been reported with other enteric infections.
Given recent literature from the FERG on the G. lam-
blia-specific global morbidity [5] and the fact that Giar-
dia is a major contributor to food and waterborne
illnesses in the United States [2], understanding the as-
sociation between acute infection and these chronic se-
quelae is important and will yield more accurate
estimates of global disease morbidity.
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